The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zofran 4mg/2ml Solution for Injection or Infusion

4 mg/2ml Solution for injection/infusion

Novartis Ireland LimitedPA0896/036/001

Main Information

Trade NameZofran 4mg/2ml Solution for Injection or Infusion
Active SubstancesOndansetron hydrochloride dihydrate
Strength4 mg/2ml
Dosage FormSolution for injection/infusion
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/036/001

Group Information

ATC CodeA04AA Serotonin (5HT3) antagonists
A04AA01 ondansetron


Licence Issued27/06/1990
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back